CASE REPORT article
Front. Hematol.
Sec. Immunobiology and Immunotherapy
Volume 4 - 2025 | doi: 10.3389/frhem.2025.1547209
Teclistamab in the treatment of idiopathic immune thrombocytopenia in patients with multiple myeloma
Provisionally accepted
Asis Shrestha1,2
Anup Kumar Trikannad Ashwini Kumar1,2
Soumya Pandey2,3Tanvi Patel1,2Hira Imad Cheema1,2Syed Mujtaba Naqvi1,2Ramya Bachu1,2Trilok Shrivastava1,2Sharmilan Thanendrarajan1,2
Maurizio Zangari1,2Samer Al Hadidi1,2
Frits van Rhee1,2
Carolina Schinke1,2*- 1Myeloma Center, Winthrop P. Rockefeller Cancer Institute, Little Rock, United States
- 2University of Arkansas for Medical Sciences, Little Rock, United States
- 3Department of Pathology, College of Medicine, Little Rock, United States
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
No abstract for case report
Keywords: immune thrombocytopenia1, teclistamab2, BCMA3, Multiple Myeloma4, plasma cells5
Received: 17 Dec 2024; Accepted: 28 Mar 2025.
Copyright: © 2025 Shrestha, Trikannad Ashwini Kumar, Pandey, Patel, Cheema, Naqvi, Bachu, Shrivastava, Thanendrarajan, Zangari, Al Hadidi, van Rhee and Schinke. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Carolina Schinke, Myeloma Center, Winthrop P. Rockefeller Cancer Institute, Little Rock, United States
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.